Berger Dietmar 4
4 · Atara Biotherapeutics, Inc. · Filed May 7, 2018
Insider Transaction Report
Form 4
Berger Dietmar
Global Head of R&D
Transactions
- Award
Employee Stock Option (Right to Buy)
2018-05-07+85,000→ 85,000 totalExercise: $42.05Exp: 2025-05-06→ Common Stock (85,000 underlying) - Award
Common Stock
2018-05-07+50,000→ 50,000 total
Footnotes (2)
- [F1]25% of the shares subject to restricted stock units vest on May 7, 2019 and the remaining shares vest in equal annual installments over the following 3 years.
- [F2]25% of the shares subject to the option vest on May 7, 2019 and the remaining shares vest in equal monthly installments over the following 36 months.